Log In
Print this Print this

Oxaydo, oxycodone (Aversion) (formerly Acurox, Oxecta)

  Manage Alerts
Collapse Summary General Information
Company Acura Pharmaceuticals Inc.
DescriptionOral immediate-release oxycodone tablets without niacin utilizing Aversion abuse-deterrent technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat acute and chronic moderate to severe pain; Treat moderate to severe pain
Regulatory Designation

U.S. - Priority Review (Treat moderate to severe pain)


Egalet Corp.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today